Skip to content
Subscriber Only

AstraZeneca Says Coronavirus Outbreak to Hit Results

  • Drugmaker gets about a fifth of its revenue from China
  • Pascal Soriot said outbreak has caused “limited disruption”
AstraZeneca Plc Medical Tablets As U.K. Pharma Company Rejects Pfizer's $98.7 Billion Bid

Photographer: Simon Dawson/Bloomberg

Updated on

Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.

AstraZeneca Plc signaled that a long-awaited profit rebound will be dented by the impact of the coronavirus epidemic spreading in China, one of the U.K. drugmaker’s key markets.